Annovis Bio Inc

Insider buying surges at Annovis Bio as Michael Hoffman piles on shares, signaling confidence in the company’s Buntanetap pipeline and upcoming public offering.

Insider buying spurs confidence in Annovis Bio’s neuro‑degenerative pipeline – learn how director Hoffman’s purchases signal long‑term value and impact investors.